Orgenesis Company
Orgenesis focuses on a novel therapeutic treatment for diabetes by correcting malfunctioning organs with new functional tissues.
Technology:
Cell-based gene therapy, Regenerative Medicine
Industry:
Delisted, Regenerative Medicine
Headquarters:
White Plains, New York, United States
Zip:
101-250
Founded Date:
2008-01-01
Employees Number:
101-250
Funding Status:
IPO
Acquisitions Number:
2
Investors Number:
2
Total Funding:
29315000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-09-28
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership